| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0001792> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0004793> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0008059> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0014499> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0026062> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0026882> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0042720> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0162326> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0162327> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C0205847> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C2732543> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C2936621> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C2936622> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C2936623> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C2936624> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C2936625> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C3658241> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C3658242> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C3658243> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C3713756> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C4288871> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C4687476> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C5391442> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/34346744_HAS_TOPIC_C5392992>
?:authorAffiliation	[\'Department of Infectious Diseases, Southwest Hospital, Third Military Medical Universitygrid.410570.7 (Army Medial University), Chongqing, China.\', \'Chongqing Key Laboratory for Research of Infectious Diseases, Chongqing, China.\', \'Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China.\', \'Beijing Novogene Company Limited, Beijing, China.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Chen_Yaokai> <https://research.tib.eu/covid-19/entity/Dan_Yunjie> <https://research.tib.eu/covid-19/entity/Deng_Guohong> <https://research.tib.eu/covid-19/entity/He_Weiwei> <https://research.tib.eu/covid-19/entity/Lu_Yanqiu> <https://research.tib.eu/covid-19/entity/Sun_Fengming> <https://research.tib.eu/covid-19/entity/Tan_Shun> <https://research.tib.eu/covid-19/entity/Tan_Wenting> <https://research.tib.eu/covid-19/entity/Tan_Zhaoxia> <https://research.tib.eu/covid-19/entity/Wan_Xing> <https://research.tib.eu/covid-19/entity/Wang_Xiuhua> <https://research.tib.eu/covid-19/entity/Xiang_Xiaomei> <https://research.tib.eu/covid-19/entity/Xu_Junli> <https://research.tib.eu/covid-19/entity/Zhang_Juan> <https://research.tib.eu/covid-19/entity/Zhang_Wei> <https://research.tib.eu/covid-19/entity/Zhou_Yi>
?:doi	10.1128/Spectrum.00261-21
?:doi	<https://research.tib.eu/covid-19/entity/10.1128/Spectrum.00261-21>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_U.S._Gov%27t%2C_Non-P.H.S.>
?:journal	Microbiology spectrum
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34346744>
?:pmid	<https://research.tib.eu/covid-19/entity/34346744>
?:pmid	34346744
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.814
?:rankingScore_hIndex	21
?:title	SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34346744>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34346744>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all